INO - INOVIO PHARMACEUTICALS, INC.

QQQ $ 482.88 $ 2.24 (0.47 %)

DIA $ 408.91 $ 0.43 (0.11 %)

SPY $ 560.81 $ 1.92 (0.34 %)

TLT $ 98.72 $ 0.06 (0.06 %)

GLD $ 232.16 $ -0.31 (-0.13 %)

Previous Close

$ 7.63

Open

Bid

$ 7.62 x 145

Ask

$ 7.64 x 200

Day's Range

-- - --

52 Week Range

$ 3.89 - $ 14.75

Volume

282,376

Average Volume

Market Cap

207.52M

Beta (5Y Monthly)

$ 0.84

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-08-2024	06-30-2024	10-Q
2	05-13-2024	03-31-2024	10-Q
3	03-06-2024	12-31-2023	10-K
4	11-09-2023	09-30-2023	10-Q
5	08-09-2023	06-30-2023	10-Q
6	05-10-2023	03-31-2023	10-Q
7	03-01-2023	12-31-2022	10-K
8	11-08-2022	09-30-2022	10-Q
9	08-09-2022	06-30-2022	10-Q
10	05-10-2022	03-31-2022	10-Q
11	03-01-2022	12-31-2021	10-K
12	11-09-2021	09-30-2021	10-Q
13	08-09-2021	06-30-2021	10-Q
14	05-10-2021	03-31-2021	10-Q
15	03-01-2021	12-31-2020	10-K
16	11-09-2020	09-30-2020	10-Q
17	08-10-2020	06-30-2020	10-Q
18	05-11-2020	03-31-2020	10-Q
19	03-12-2020	12-31-2019	10-K
20	11-12-2019	09-30-2019	10-Q
21	08-08-2019	06-30-2019	10-Q
22	05-09-2019	03-31-2019	10-Q
23	03-12-2019	12-31-2018	10-K
24	11-08-2018	09-30-2018	10-Q
25	08-07-2018	06-30-2018	10-Q
26	05-09-2018	03-31-2018	10-Q
27	03-14-2018	12-31-2017	10-K
28	11-08-2017	09-30-2017	10-Q
29	08-08-2017	06-30-2017	10-Q
30	05-10-2017	03-31-2017	10-Q
31	03-15-2017	12-31-2016	10-K
32	11-09-2016	09-30-2016	10-Q
33	08-08-2016	06-30-2016	10-Q
34	05-09-2016	03-31-2016	10-Q
35	03-14-2016	12-31-2015	10-K
36	11-09-2015	09-30-2015	10-Q
37	08-10-2015	06-30-2015	10-Q
38	05-11-2015	03-31-2015	10-Q
39	03-16-2015	12-31-2014	10-K
40	11-10-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

'Mpox In Wayne County: Health Department C...
08/21/2024 19:49:51

https://www.fox2detroit.com/news/mpox-wayne-county-health-department-confirms-first-case-since-2022?taid=66c643be103e400001efc3...

Africa CDC Director General Says Mpox Vacc...
08/20/2024 14:01:11

- Reuters

Vaccine Group Gavi Says It Has Up To $500M...
08/15/2024 17:02:57

- Reuters

WHO Says Actively Engaging With Swedish He...
08/15/2024 16:52:17

- Reuters

WHO Says Expert Committee Will Propose Ado...
08/14/2024 17:55:52

- Reuters

WHO Director-General Tedros Adhanom Ghebre...
08/14/2024 17:27:30

https://x.com/i/broadcasts/1kvJpbgRNWgKE

WHO Press Conference On Potential Mpox Eme...
08/14/2024 17:25:05

https://x.com/i/broadcasts/1kvJpbgRNWgKE

Africa CDC Declares Mpox A Public Health E...
08/13/2024 13:51:36

- Director General

Oppenheimer Maintains Outperform on Inovio...
08/12/2024 13:40:38

Oppenheimer analyst Jay Olson maintains Inovio Pharmaceuticals (NASDAQ:INO) with a Outperform and lowers the price target fr...

RBC Capital Maintains Sector Perform on In...
08/09/2024 19:23:35

RBC Capital analyst Gregory Renza maintains Inovio Pharmaceuticals (NASDAQ:INO) with a Sector Perform and lowers the price t...

Inovio Pharmaceuticals Q2 2024 GAAP EPS $(...
08/08/2024 20:38:05

Inovio Pharmaceuticals (NASDAQ:INO) reported quarterly losses of $(1.19) per share which missed the analyst consensus estimate ...

Africa CDC Plans To Declare Regional Mpox ...
08/08/2024 15:45:04

- Bloomberg

'WHO Warns On Deadlier Strain Of Mpox' - A...
08/05/2024 16:09:25

https://www.axios.com/2024/08/05/mpox-who-warning-africaThe World Health Organization is weighing discussions on whether to dec...

Inovio Receives Advanced Therapy Medicinal...
07/25/2024 20:24:20

Data reviewed complies with standards that would be used to evaluate an EU Marketing Authorization ApplicationPLYMOUTH MEETING,...

HC Wainwright & Co. Reiterates Neutral on ...
07/15/2024 10:30:40

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Inovio Pharmaceuticals (NASDAQ:INO) with a Neutral and maintai...

INO-3107 Awarded The Innovation Passport D...
07/11/2024 12:18:49

Award recognizes the potential for INO-3107 to be the first therapeutic option in the United Kingdom for patients suffering fro...

INOVIO Added Included In Russell 2000 Inde...
07/01/2024 12:04:21

INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect ...

why-virios-therapeutics-shares-are-trading-lower-by-around-48-here-are-other-stocks-moving-in-mondays-mid-day-session

Why Virios Therapeutics Shares Are Trading...
05/20/2024 17:28:52

dna-medicine-focused-inovio-pharma-efficiencies-implemented-by-leadership-will-help-de-risk-its-platform-technology-analyst

DNA Medicine Focused INOVIO Pharma Efficie...
05/14/2024 18:37:32

Stephens covers INOVIO Pharmaceuticals highlighting its diverse clinical pipeline and FDA's consideration of INO-3107 Phase...

Stephens & Co. Initiates Coverage On Inovi...
05/14/2024 10:01:38

Stephens & Co. analyst Sudan Loganathan initiates coverage on Inovio Pharmaceuticals (NASDAQ:INO) with a Overweight rati...